Global Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market, By Test Type (Clinical Chemistry, Immunodiagnostics), Application (Infectious Diseases, Oncology, Endocrinology, Autoimmune Disorders, Basic Metabolite Panel, Liver Function Test, Electrolyte Panel, Kidney Function Test, Lipid Profile, Specialty Chemical Test, Thyroid Profile, Others), End User (Hospitals, Clinical Laboratories, Diagnostic Centers, Academic and Research Institutes, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market
Point of care (POC) clinical chemistry and immunodiagnostic market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 13,993.21 million by 2028 and will grow at a CAGR of 4.16% in the above mentioned forecast period.
Clinical chemistry is a branch of biochemistry dealing with the examination of body fluids for diagnostic and restorative purposes. Immunodiagnostics is a division of in vitro diagnostics which diagnose the disease on the basis of antigen antibody reactions.
The increase in incidence and prevalence of infectious diseases is amongst the important factor expected to intensify the growth and demand of point of care (POC) clinical chemistry and immunodiagnostic market. In addition, the rise in the preferences for automated clinical chemistry amongst medical professionals and rise in the healthcare initiatives from government are also expected contributes to the growth in the global market over the forecast period of 2021 to 2028. Also the high growth in aging population and the rise in the need for advanced technologies for diagnostic tests are also likely to enhance the growth of the market. Furthermore, the rise in the geriatric population and rapid change in the lifestyle and demographics are also amongst the significant factors expected to fuel the growth of the point of care (POC) clinical chemistry and immunodiagnostic market.
The increase in the number of research activities, rapid technological advancement and growing rise in the awareness about immunodiagnostics are anticipated to offer significant growth opportunities for the point of care (POC) clinical chemistry and immunodiagnostic market in the forecast period of 2021 to 2028.
However, the lack of skilled professionals along with high cost of devices are expected to curb the growth of the point of care (POC) clinical chemistry and immunodiagnostic market, whereas the stringent regulatory scenarios can challenge the growth of the point of care (POC) clinical chemistry and immunodiagnostic market.
This point of care (POC) clinical chemistry and immunodiagnostic market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on point of care (POC) clinical chemistry and immunodiagnostic market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Scope and Market Size
Point of care (POC) clinical chemistry and immunodiagnostic market is segmented on the basis of test type, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of test type, the point of care (POC) clinical chemistry and immunodiagnostic market is segmented into clinical chemistry and immunodiagnostics. Clinical chemistry has further been segmented into routine chemistry, special chemistry, drug monitoring, endocrinology, toxicology and urinalysis. Immunodiagnostics have further been segmented into enzyme-linked immunosorbent assay or ELISA and radioimmunoassay.
- The application segment of the point of care (POC) clinical chemistry and immunodiagnostic market is segmented into infectious diseases, oncology, endocrinology, autoimmune disorders, basic metabolite panel, liver function test, electrolyte panel, kidney function test, lipid profile, specialty chemical test, thyroid profile and others.
- On the basis of end user, the point of care (POC) clinical chemistry and immunodiagnostic market is segmented into hospitals, clinical laboratories, diagnostic centers, academic and research institutes and others.
Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Country Level Analysis
Point of care (POC) clinical chemistry and immunodiagnostic market is analyzed and market size insights and trends are provided by country, test type, application and end user as referenced above.
The countries covered in the point of care (POC) clinical chemistry and immunodiagnostic market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the point of care (POC) clinical chemistry and immunodiagnostic market owing to the rise in the need for advanced technologies for diagnostic tests and rise in the prevalence of several diseases and ailments among the population. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rise in the need for feasible immunoassay procedures and advanced diagnostic platforms.
The country section of the point of care (POC) clinical chemistry and immunodiagnostic market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Point of care (POC) clinical chemistry and immunodiagnostic market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point of care (POC) clinical chemistry and immunodiagnostic market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point of care (POC) clinical chemistry and immunodiagnostic market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Point of Care (POC) Clinical Chemistry and Immunodiagnostic Market Share Analysis
Point of care (POC) clinical chemistry and immunodiagnostic market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to point of care (POC) clinical chemistry and immunodiagnostic market.
The major players covered in the point of care (POC) clinical chemistry and immunodiagnostic market report are Abbott, QIAGEN, Danaher, Thermo Fisher Scientific, Inc., Beckman Coulter, Inc., Horiba, Ltd., Ortho Clinical Diagnostics, DiaSorin S.p.A., Accurex Biomedical Pvt. Ltd., ELITechGroup, Alfa Wassermann, bioMérieux SA, Bio-Rad Laboratories, Inc., Cardinal Health, Siemens Healthcare Private Limited, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Omega Diagnostics Group PLC, Hologic, Inc., Quest Diagnostics Incorporated, and Agilent Technologies among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-